TNFRSF9 and aortic stenosis: Activation of the CD137 signaling pathway in endothelial cells attenuates their protective effect against VSMCs, suggesting that the CD137-TET2 signaling pathway offers a novel therapeutic target for preventing and treating excessive VSMC proliferation or restenosis in aortic stenosis (AS) (16).